[211At]NaAt

[211At]砹化钠

Report date: 2025/12/02 09:40:39
NME

Base Information

Drug Name[211At]NaAt
Drug Alias NameTAH-1005αf-001
ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Astatine > 211At
Mechanisms of ActionFree radicals stimulants
TargetsFree radicals
Therapy Area/IndicationsThyroid Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOsaka University
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsThyroid Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A